These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 37272857)

  • 41. Antipsychotic combinations for schizophrenia.
    Ortiz-Orendain J; Castiello-de Obeso S; Colunga-Lozano LE; Hu Y; Maayan N; Adams CE
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009005. PubMed ID: 28658515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antioxidant treatments for schizophrenia.
    Magalhães PV; Dean O; Andreazza AC; Berk M; Kapczinski F
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008919. PubMed ID: 26848926
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maintenance treatment with antipsychotic drugs for schizophrenia.
    Ceraso A; Lin JJ; Schneider-Thoma J; Siafis S; Tardy M; Komossa K; Heres S; Kissling W; Davis JM; Leucht S
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD008016. PubMed ID: 32840872
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Humour-based interventions for people with schizophrenia.
    Tsujimoto Y; Nakamura Y; Banno M; Kohmura K; Tsujimoto H; Kataoka Y
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013367. PubMed ID: 34644398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).
    Ostinelli EG; Hussein M; Ahmed U; Rehman FU; Miramontes K; Adams CE
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009412. PubMed ID: 29634083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cannabis and schizophrenia.
    McLoughlin BC; Pushpa-Rajah JA; Gillies D; Rathbone J; Variend H; Kalakouti E; Kyprianou K
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004837. PubMed ID: 25314586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quetiapine versus typical antipsychotic medications for schizophrenia.
    Suttajit S; Srisurapanont M; Xia J; Suttajit S; Maneeton B; Maneeton N
    Cochrane Database Syst Rev; 2013 May; (5):CD007815. PubMed ID: 23728667
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Benzodiazepines for schizophrenia.
    Dold M; Li C; Tardy M; Khorsand V; Gillies D; Leucht S
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD006391. PubMed ID: 23152236
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Avatar Therapy for people with schizophrenia or related disorders.
    Aali G; Kariotis T; Shokraneh F
    Cochrane Database Syst Rev; 2020 May; 5(5):CD011898. PubMed ID: 32413166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chlorpromazine versus clotiapine for schizophrenia.
    Mazhari S; Esmailian S; Shah-Esmaeili A; Goughari AS; Bazrafshan A; Zare M
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011810. PubMed ID: 28387925
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Valproate for schizophrenia.
    Wang Y; Xia J; Helfer B; Li C; Leucht S
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD004028. PubMed ID: 27884042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Benzodiazepines for psychosis-induced aggression or agitation.
    Zaman H; Sampson SJ; Beck AL; Sharma T; Clay FJ; Spyridi S; Zhao S; Gillies D
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003079. PubMed ID: 29219171
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fluphenazine decanoate (depot) and enanthate for schizophrenia.
    Maayan N; Quraishi SN; David A; Jayaswal A; Eisenbruch M; Rathbone J; Asher R; Adams CE
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD000307. PubMed ID: 25654768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risperidone versus placebo for schizophrenia.
    Rattehalli RD; Zhao S; Li BG; Jayaram MB; Xia J; Sampson S
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD006918. PubMed ID: 27977041
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aripiprazole versus other atypical antipsychotics for schizophrenia.
    Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S
    Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chlorpromazine dose for people with schizophrenia.
    Dudley K; Liu X; De Haan S
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007778. PubMed ID: 28407198
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Haloperidol versus placebo for schizophrenia.
    Adams CE; Bergman H; Irving CB; Lawrie S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD003082. PubMed ID: 24242360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psychosocial interventions for people with both severe mental illness and substance misuse.
    Hunt GE; Siegfried N; Morley K; Sitharthan T; Cleary M
    Cochrane Database Syst Rev; 2013 Oct; (10):CD001088. PubMed ID: 24092525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
    Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Asenapine versus placebo for schizophrenia.
    Hay A; Byers A; Sereno M; Basra MK; Dutta S
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011458. PubMed ID: 26599405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.